Skip to content

Clinical trials

Phase 2 Brain Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Neoplasms Phase: Phase 2 Country / region: Italy Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20042
20051
20072
20091
20112
20131
20141
20154
20161
20172
20192
20211
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting3
Terminated3
Unknown status3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC4
Novartis Pharmaceuticals3
Eli Lilly and Company2
GlaxoSmithKline2
Pfizer2
AbbVie1
Apollomics Inc.1
AstraZeneca1
Bristol-Myers Squibb1
CNS Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Neoplasms24
Glioblastoma7
Melanoma7
Breast Neoplasms6
Carcinoma, Non-Small-Cell Lung6
Central Nervous System Neoplasms6
Glioma4
Gliosarcoma4
Neoplasms3
Pancreatic Neoplasms3

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.